Published in Restor Neurol Neurosci on January 01, 2009
Therapeutic effects of hMAPC and hMSC transplantation after stroke in mice. PLoS One (2012) 1.00
The Dark Side of the Force - Constraints and Complications of Cell Therapies for Stroke. Front Neurol (2015) 0.89
Transplantation of cryopreserved human umbilical cord blood mononuclear cells does not induce sustained recovery after experimental stroke in spontaneously hypertensive rats. J Cereb Blood Flow Metab (2013) 0.80
Intracerebroventricular Transplantation of Cord Blood-Derived Neural Progenitors in a Child With Severe Global Brain Ischemic Injury. Cell Med (2010) 0.79
Label-Free Imaging of Umbilical Cord Tissue Morphology and Explant-Derived Cells. Stem Cells Int (2016) 0.77
Enhancing endogenous stem cells in the newborn via delayed umbilical cord clamping. Neural Regen Res (2015) 0.75
Term versus preterm cord blood cells for the prevention of preterm brain injury. Pediatr Res (2017) 0.75
Immunomodulators and microRNAs as neurorestorative therapy for ischemic stroke. Neural Regen Res (2017) 0.75
Long-term lymphohematopoietic reconstitution by a single CD34-low/negative hematopoietic stem cell. Science (1996) 12.54
Direct isolation of human central nervous system stem cells. Proc Natl Acad Sci U S A (2000) 10.88
Pathobiology of ischaemic stroke: an integrated view. Trends Neurosci (1999) 10.61
AC133, a novel marker for human hematopoietic stem and progenitor cells. Blood (1997) 7.84
Dye efflux studies suggest that hematopoietic stem cells expressing low or undetectable levels of CD34 antigen exist in multiple species. Nat Med (1997) 6.13
A novel five-transmembrane hematopoietic stem cell antigen: isolation, characterization, and molecular cloning. Blood (1997) 5.04
Outcome of cord-blood transplantation from related and unrelated donors. Eurocord Transplant Group and the European Blood and Marrow Transplantation Group. N Engl J Med (1997) 4.71
Intravenous administration of human umbilical cord blood reduces behavioral deficits after stroke in rats. Stroke (2001) 4.64
Evidence for a mitotic clock in human hematopoietic stem cells: loss of telomeric DNA with age. Proc Natl Acad Sci U S A (1994) 4.57
Administration of CD34+ cells after stroke enhances neurogenesis via angiogenesis in a mouse model. J Clin Invest (2004) 4.04
Cellular and molecular mechanisms of neural repair after stroke: making waves. Ann Neurol (2006) 2.83
Transplantation of umbilical cord blood after myeloablative therapy: analysis of engraftment. Blood (1992) 2.77
Detection of the ischemic penumbra using pH-weighted MRI. J Cereb Blood Flow Metab (2006) 2.77
Intravenous bone marrow stromal cell therapy reduces apoptosis and promotes endogenous cell proliferation after stroke in female rat. J Neurosci Res (2003) 2.61
Central nervous system entry of peripherally injected umbilical cord blood cells is not required for neuroprotection in stroke. Stroke (2004) 2.49
Stroke incidence and prevalence in Europe: a review of available data. Eur J Neurol (2006) 2.42
Allogeneic sibling umbilical-cord-blood transplantation in children with malignant and non-malignant disease. Lancet (1995) 2.40
Infusion of human umbilical cord blood cells in a rat model of stroke dose-dependently rescues behavioral deficits and reduces infarct volume. Stroke (2004) 2.40
Cell transplantation therapy for stroke. Stroke (2007) 2.30
Behavioral improvement in a primate Parkinson's model is associated with multiple homeostatic effects of human neural stem cells. Proc Natl Acad Sci U S A (2007) 2.19
Therapeutic benefit of bone marrow stromal cells administered 1 month after stroke. J Cereb Blood Flow Metab (2006) 2.10
Transplantation of a novel cell line population of umbilical cord blood stem cells ameliorates neurological deficits associated with ischemic brain injury. Stem Cells Dev (2005) 2.07
Transplantation of cryopreserved human embryonal carcinoma-derived neurons (NT2N cells) promotes functional recovery in ischemic rats. Exp Neurol (1998) 1.89
Angiopoietin1/Tie2 and VEGF/Flk1 induced by MSC treatment amplifies angiogenesis and vascular stabilization after stroke. J Cereb Blood Flow Metab (2007) 1.89
Plasticity of cortical projections after stroke. Neuroscientist (2003) 1.86
Mobilized peripheral blood cells administered intravenously produce functional recovery in stroke. Cell Transplant (2003) 1.81
Intravenous versus intrastriatal cord blood administration in a rodent model of stroke. J Neurosci Res (2003) 1.79
I.V. infusion of brain-derived neurotrophic factor gene-modified human mesenchymal stem cells protects against injury in a cerebral ischemia model in adult rat. Neuroscience (2005) 1.70
Cord blood rescues stroke-induced changes in splenocyte phenotype and function. Exp Neurol (2006) 1.69
Anti-inflammatory effects of human cord blood cells in a rat model of stroke. Stem Cells Dev (2005) 1.67
Coupling of angiogenesis and neurogenesis in cultured endothelial cells and neural progenitor cells after stroke. J Cereb Blood Flow Metab (2007) 1.64
High-efficiency recovery of functional hematopoietic progenitor and stem cells from human cord blood cryopreserved for 15 years. Proc Natl Acad Sci U S A (2003) 1.60
Transplantation of human neural stem cells exerts neuroprotection in a rat model of Parkinson's disease. J Neurosci (2006) 1.59
Stem cells and neurological diseases. Cell Prolif (2008) 1.45
Stroke epidemiology, prevention, and management strategies at a regional level: Latin America and the Caribbean. Lancet Neurol (2007) 1.42
Acute treatment and long-term management of stroke in developing countries. Lancet Neurol (2007) 1.41
Transplantation of hNT neurons into the ischemic cortex: cell survival and effect on sensorimotor behavior. J Neurosci Res (2006) 1.39
Stroke induces gene profile changes associated with neurogenesis and angiogenesis in adult subventricular zone progenitor cells. J Cereb Blood Flow Metab (2006) 1.39
Intracerebral peripheral blood stem cell (CD34+) implantation induces neuroplasticity by enhancing beta1 integrin-mediated angiogenesis in chronic stroke rats. J Neurosci (2006) 1.34
Combination therapy of stroke in rats with a nitric oxide donor and human bone marrow stromal cells enhances angiogenesis and neurogenesis. Brain Res (2004) 1.33
Cell-based therapy in ischemic stroke. Expert Rev Neurother (2008) 1.33
Development of human mast cells from umbilical cord blood cells by recombinant human and murine c-kit ligand. Proc Natl Acad Sci U S A (1993) 1.30
Human cord blood-derived cells attain neuronal and glial features in vitro. J Cell Sci (2002) 1.29
Expression of insulin-like growth factor 1 and receptor in ischemic rats treated with human marrow stromal cells. Brain Res (2004) 1.28
Intravenous administration of glial cell line-derived neurotrophic factor gene-modified human mesenchymal stem cells protects against injury in a cerebral ischemia model in the adult rat. J Neurosci Res (2006) 1.27
Intracerebral transplantation of porcine choroid plexus provides structural and functional neuroprotection in a rodent model of stroke. Stroke (2004) 1.25
Therapeutic benefits by human mesenchymal stem cells (hMSCs) and Ang-1 gene-modified hMSCs after cerebral ischemia. J Cereb Blood Flow Metab (2007) 1.21
Evolving paradigms in neuroimaging of the ischemic penumbra. Stroke (2004) 1.20
Expression of neural markers in human umbilical cord blood. Exp Neurol (2001) 1.18
Cytokines produced by cultured human umbilical cord blood (HUCB) cells: implications for brain repair. Exp Neurol (2006) 1.14
Potential of stem/progenitor cells in treating stroke: the missing steps in translating cell therapy from laboratory to clinic. Regen Med (2008) 1.13
The ischemic penumbra: identification, evolution and treatment concepts. Cerebrovasc Dis (2004) 1.11
Human umbilical cord blood progenitors: the potential of these hematopoietic cells to become neural. Stem Cells (2005) 1.09
Induction of neurotrophin expression via human adult mesenchymal stem cells: implication for cell therapy in neurodegenerative diseases. Cell Transplant (2007) 1.07
Comparison of in vivo and in vitro gene expression profiles in subventricular zone neural progenitor cells from the adult mouse after middle cerebral artery occlusion. Neuroscience (2007) 1.07
Cell therapy for stroke. NeuroRx (2004) 1.06
Stimulating circle of Willis nerve fibers preserves the diffusion-perfusion mismatch in experimental stroke. Stroke (2007) 0.97
Nitric oxide regulates Angiopoietin1/Tie2 expression after stroke. Neurosci Lett (2006) 0.96
Angiogenesis and stem cell transplantation as potential treatments of cerebral ischemic stroke. Pathophysiology (2005) 0.95
Neural stem-like cell line derived from a nonhematopoietic population of human umbilical cord blood. Stem Cells Dev (2006) 0.94
Human umbilical cord blood cells do not improve sensorimotor or cognitive outcome following transient middle cerebral artery occlusion in rats. Brain Res (2006) 0.93
Human umbilical cord blood cells can be induced to express markers for neurons and glia. Cell Transplant (2002) 0.93
Limitations of intravenous human bone marrow CD133+ cell grafts in stroke rats. Brain Res (2005) 0.93
Transplantation of vascular endothelial growth factor-transfected neural stem cells into the rat brain provides neuroprotection after transient focal cerebral ischemia. Neurosurgery (2005) 0.92
Human cord blood CD34+ cells and behavioral recovery following focal cerebral ischemia in rats. Acta Neurobiol Exp (Wars) (2006) 0.91
Growth factors and stem cells as treatments for stroke recovery. Phys Med Rehabil Clin N Am (2003) 0.91
Voltage-sensitive and ligand-gated channels in differentiating neural stem-like cells derived from the nonhematopoietic fraction of human umbilical cord blood. Stem Cells (2005) 0.91
Transplantation of a novel human cord blood-derived neural-like stem cell line in a rat model of cortical infarct. Stem Cells Dev (2007) 0.90
Transplantation of post-mitotic human neuroteratocarcinoma-overexpressing Nurr1 cells provides therapeutic benefits in experimental stroke: in vitro evidence of expedited neuronal differentiation and GDNF secretion. J Neurosci Res (2007) 0.90
Umbilical cord blood cells and brain stroke injury: bringing in fresh blood to address an old problem. J Clin Invest (2004) 0.89
Acute ischemic stroke: overview of recent therapeutic developments. Annu Rev Med (2007) 0.87
Human trophoblast contains an intracellular protein reactive with an antibody against CD133--a novel marker for trophoblast. Placenta (2001) 0.86
Experimental treatment of stroke in spontaneously hypertensive rats by CD34+ and CD34- cord blood cells. Ger Med Sci (2005) 0.85
Gene profiles within the adult subventricular zone niche: proliferation, differentiation and migration of neural progenitor cells in the ischemic brain. Curr Mol Med (2007) 0.85
Stem cells from bone marrow, umbilical cord blood and peripheral blood for clinical application: current status and future application. Crit Rev Oncol Hematol (1996) 0.85
Neuronal differentiation of human umbilical cord blood neural stem-like cell line. Neurodegener Dis (2006) 0.84
The ischemic stroke patient who worsens: new assessment and management approaches. Rev Neurol Dis (2007) 0.84
Cell delivery to the central nervous system. Adv Drug Deliv Rev (2000) 0.84
Neural phenotype expression of cultured human cord blood cells in vitro. Neuroreport (2001) 0.83
Human umbilical cord blood (HUCB) cells for central nervous system repair. Neurotox Res (2003) 0.83
Physiologically based model of acute ischemic stroke. J Cereb Blood Flow Metab (2002) 0.83
Ex vivo gene therapy: transplantation of neurotrophic factor-secreting cells for cerebral ischemia. Front Biosci (2006) 0.83
Therapeutic efficacy of intraventricular cyclosporine A and methylprednisolone on a global cerebral ischemia model in rats. Neurol Res (2005) 0.81
Transduction efficiency of cell lines and hematopoietic stem cells correlates with retrovirus receptor mRNA levels. Stem Cells (1997) 0.81
Human cord blood: a source of transplantable stem cells? Bone Marrow Transplant (1992) 0.81
Reconstruction of cortical circuitry. Prog Brain Res (2000) 0.80
Drug therapy for the secondary prevention of stroke in hypertensive patients: current issues and options. Drugs (2007) 0.80
Transplantation of human umbilical cord blood cells in the repair of CNS diseases. Expert Opin Biol Ther (2004) 0.80
Human umbilical cord blood CD34+ cell purification with high yield of early progenitors. J Hematother (1993) 0.79
Functional consequences of embryonic neocortex transplanted to rats with prefrontal cortex lesions. Behav Neurosci (1987) 0.77
Cell transplants offer promise for stroke recovery. J Cardiovasc Nurs (2003) 0.76
Origin, evolution, and genotyping of emergent porcine epidemic diarrhea virus strains in the United States. MBio (2013) 4.06
Exploring the functional landscape of gene expression: directed search of large microarray compendia. Bioinformatics (2007) 3.59
A simple, assumption-free, and clinically interpretable approach for analysis of modified Rankin outcomes. Stroke (2012) 2.57
Remote ischemic perconditioning is effective alone and in combination with intravenous tissue-type plasminogen activator in murine model of embolic stroke. Stroke (2012) 2.46
Remote evaluation of acute ischemic stroke: reliability of National Institutes of Health Stroke Scale via telestroke. Stroke (2003) 2.17
Inhibition of p21-mediated ROS accumulation can rescue p21-induced senescence. EMBO J (2002) 2.07
SDF-1 (CXCL12) is upregulated in the ischemic penumbra following stroke: association with bone marrow cell homing to injury. J Neuropathol Exp Neurol (2004) 1.94
Targets for vascular protection after acute ischemic stroke. Stroke (2004) 1.88
Postischemic brain injury is exacerbated in mice lacking the kinin B2 receptor. Hypertension (2006) 1.80
Matrix metalloproteinase-9 in an exploratory trial of intravenous minocycline for acute ischemic stroke. Stroke (2011) 1.80
Minocycline up-regulates Bcl-2 and protects against cell death in mitochondria. J Biol Chem (2004) 1.79
Predicting gene function in a hierarchical context with an ensemble of classifiers. Genome Biol (2008) 1.78
Involvement of vascular peroxidase 1 in angiotensin II-induced vascular smooth muscle cell proliferation. Cardiovasc Res (2011) 1.70
Delayed minocycline inhibits ischemia-activated matrix metalloproteinases 2 and 9 after experimental stroke. BMC Neurosci (2006) 1.69
Minocycline to improve neurologic outcome in stroke (MINOS): a dose-finding study. Stroke (2010) 1.69
HB-EGF is a potent inducer of tumor growth and angiogenesis. Cancer Res (2004) 1.63
The great migration of bone marrow-derived stem cells toward the ischemic brain: therapeutic implications for stroke and other neurological disorders. Prog Neurobiol (2011) 1.61
Who's in favor of translational cell therapy for stroke: STEPS forward please? Cell Transplant (2009) 1.60
The miR-200 family regulates TGF-β1-induced renal tubular epithelial to mesenchymal transition through Smad pathway by targeting ZEB1 and ZEB2 expression. Am J Physiol Renal Physiol (2011) 1.57
Menstrual blood cells display stem cell-like phenotypic markers and exert neuroprotection following transplantation in experimental stroke. Stem Cells Dev (2010) 1.51
Improving modified Rankin Scale assessment with a simplified questionnaire. Stroke (2010) 1.50
Low dose intravenous minocycline is neuroprotective after middle cerebral artery occlusion-reperfusion in rats. BMC Neurol (2004) 1.47
p53 induction and activation of DDR1 kinase counteract p53-mediated apoptosis and influence p53 regulation through a positive feedback loop. EMBO J (2003) 1.44
Optimal delivery of minocycline to the brain: implication for human studies of acute neuroprotection. Exp Neurol (2004) 1.40
Bone marrow grafts restore cerebral blood flow and blood brain barrier in stroke rats. Brain Res (2004) 1.40
Pathophysiology and treatment of stroke in sickle-cell disease: present and future. Lancet Neurol (2006) 1.39
The neuroblast and angioblast chemotaxic factor SDF-1 (CXCL12) expression is briefly up regulated by reactive astrocytes in brain following neonatal hypoxic-ischemic injury. BMC Neurosci (2005) 1.38
Cell-based therapy in ischemic stroke. Expert Rev Neurother (2008) 1.33
Rural-urban differences in acute stroke management practices: a modifiable disparity. Arch Neurol (2008) 1.33
Long-term upregulation of inflammation and suppression of cell proliferation in the brain of adult rats exposed to traumatic brain injury using the controlled cortical impact model. PLoS One (2013) 1.33
Therapeutic targets and limits of minocycline neuroprotection in experimental ischemic stroke. BMC Neurosci (2009) 1.33
Wharton's jelly-derived mesenchymal stem cells: phenotypic characterization and optimizing their therapeutic potential for clinical applications. Int J Mol Sci (2013) 1.31
Minocycline and tissue-type plasminogen activator for stroke: assessment of interaction potential. Stroke (2009) 1.30
Severity of controlled cortical impact traumatic brain injury in rats and mice dictates degree of behavioral deficits. Brain Res (2009) 1.27
Toll-like receptor 3 (TLR3) induces apoptosis via death receptors and mitochondria by up-regulating the transactivating p63 isoform alpha (TAP63alpha). J Biol Chem (2011) 1.27
Microglia activation as a biomarker for traumatic brain injury. Front Neurol (2013) 1.23
Minocycline for short-term neuroprotection. Pharmacotherapy (2006) 1.23
Intravenous grafts recapitulate the neurorestoration afforded by intracerebrally delivered multipotent adult progenitor cells in neonatal hypoxic-ischemic rats. J Cereb Blood Flow Metab (2008) 1.22
The impact of incomplete knowledge on evaluation: an experimental benchmark for protein function prediction. Bioinformatics (2009) 1.21
Directing experimental biology: a case study in mitochondrial biogenesis. PLoS Comput Biol (2009) 1.20
A telestroke network enhances recruitment into acute stroke clinical trials. Stroke (2010) 1.19
Increased expression of Golgi phosphoprotein-3 is associated with tumor aggressiveness and poor prognosis of prostate cancer. Diagn Pathol (2012) 1.19
Simplified modified rankin scale questionnaire: reproducibility over the telephone and validation with quality of life. Stroke (2011) 1.19
Notch-induced rat and human bone marrow stromal cell grafts reduce ischemic cell loss and ameliorate behavioral deficits in chronic stroke animals. Stem Cells Dev (2009) 1.18
Hematopoietic origin of glomerular mesangial cells. Blood (2002) 1.17
Toward cell therapy using placenta-derived cells: disease mechanisms, cell biology, preclinical studies, and regulatory aspects at the round table. Stem Cells Dev (2010) 1.17
Teleneurology applications: Report of the Telemedicine Work Group of the American Academy of Neurology. Neurology (2013) 1.17
Hypertension after experimental cerebral ischemia: candesartan provides neurovascular protection. J Hypertens (2006) 1.17
Neural progenitor NT2N cell lines from teratocarcinoma for transplantation therapy in stroke. Prog Neurobiol (2008) 1.15
Potential of stem/progenitor cells in treating stroke: the missing steps in translating cell therapy from laboratory to clinic. Regen Med (2008) 1.13
Minocycline development for acute ischemic stroke. Transl Stroke Res (2011) 1.12
Human umbilical cord blood cell grafts for brain ischemia. Cell Transplant (2009) 1.12
The immunology of traumatic brain injury: a prime target for Alzheimer's disease prevention. J Neuroinflammation (2012) 1.12
Mice lacking the matrix metalloproteinase-9 gene reduce renal interstitial fibrosis in obstructive nephropathy. Am J Physiol Renal Physiol (2010) 1.12
Behavioral and histological characterization of intrahippocampal grafts of human bone marrow-derived multipotent progenitor cells in neonatal rats with hypoxic-ischemic injury. Cell Transplant (2006) 1.10
A web-based telestroke system facilitates rapid treatment of acute ischemic stroke patients in rural emergency departments. J Emerg Med (2008) 1.09
Remote evaluation of acute ischemic stroke in rural community hospitals in Georgia. Stroke (2004) 1.08
In vivo animal stroke models: a rationale for rodent and non-human primate models. Transl Stroke Res (2013) 1.07
Sex-independent neuroprotection with minocycline after experimental thromboembolic stroke. Exp Transl Stroke Med (2011) 1.07
Mutation analysis of APC gene in gastric cancer with microsatellite instability. World J Gastroenterol (2002) 1.06
Cyclosporine-A as a neuroprotective agent against stroke: its translation from laboratory research to clinical application. Neuropeptides (2011) 1.06
Kallikrein gene transfer protects against ischemic stroke by promoting glial cell migration and inhibiting apoptosis. Hypertension (2003) 1.05
Intravenous grafts of amniotic fluid-derived stem cells induce endogenous cell proliferation and attenuate behavioral deficits in ischemic stroke rats. PLoS One (2012) 1.05
Transplantation of bone marrow-derived stem cells: a promising therapy for stroke. Cell Transplant (2007) 1.04
The ventral hippocampus is the embryonic origin for adult neural stem cells in the dentate gyrus. Neuron (2013) 1.04
Roles of TRPV1 and neuropeptidergic receptors in dorsal root reflex-mediated neurogenic inflammation induced by intradermal injection of capsaicin. Mol Pain (2007) 1.03
cAMP differentially regulates gamma-globin gene expression in erythroleukemic cells and primary erythroblasts through c-Myb expression. Biochem Biophys Res Commun (2006) 1.02
Quantitative analyses of matrix metalloproteinase activity after traumatic brain injury in adult rats. Brain Res (2009) 1.02
Cell therapy for stroke: emphasis on optimizing safety and efficacy profile of endothelial progenitor cells. Curr Pharm Des (2012) 1.01
Chronic high-fat diets induce oxide injuries and fibrogenesis of pancreatic cells in rats. Pancreas (2008) 1.01
Yeast metabolic and signaling genes are required for heat-shock survival and have little overlap with the heat-induced genes. Proc Natl Acad Sci U S A (2013) 1.01
Amnion: a potent graft source for cell therapy in stroke. Cell Transplant (2009) 1.01
Tactics for vascular protection after acute ischemic stroke. Pharmacotherapy (2005) 1.01
The treatment of neurodegenerative disorders using umbilical cord blood and menstrual blood-derived stem cells. Cell Transplant (2010) 1.00
Kallikrein protects against ischemic stroke by inhibiting apoptosis and inflammation and promoting angiogenesis and neurogenesis. Hum Gene Ther (2006) 0.99
Recent Studies Assessing the Proliferative Capability of a Novel Adult Stem Cell Identified in Menstrual Blood. Open Stem Cell J (2011) 0.99